FDA Panel Recommends Pulling Preterm Birth Drug From the Market

The agency has weighed years of study that showed the treatment given accelerated approval 11 years ago was not effective.

Comments

No comments yet. Why don’t you start the discussion?

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.